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Abstract
Objectives. To determine the influence of disease-related variables on hand cortical bone loss in women
with early inflammatory arthritis (IA), and whether hand cortical bone mass predicts subsequent joint
damage.
Method. Adults aged 516 years with recent onset of IA were recruited to the Norfolk Arthritis Register
between 1990 and 1998, and followed prospectively. At baseline, patients had their joints examined for
swelling and tenderness and had CRP and disease activity 28-joint assessment score (DAS-28) measured.
Radiographs of the hands were performed in a subgroup of patients at Year 1 and at follow-up, which
were assessed using digital X-ray radiogrammetry (DXR). They were also evaluated for the presence
of erosions using Larsen’s method. Linear mixed models were used to investigate whether disease-related
factors predicted change in DXR–areal bone mineral density (BMDa). We also evaluated whether DXR–
BMDa predicted the subsequent occurrence of erosive disease.
Results. Two hundred and four women, mean (S.D.) age 55.1 (14.0) years, were included. Median
follow-up between radiographs was 4 years. The mean within-subject change in BMDa was
0.024g/cm
2 equivalent to 1% decline per year. After adjustment for age, height and weight, compared
with those within the lower tertile for CRP, those in the upper tertile had greater subsequent loss of bone.
This was true also for DAS-28 and Larsen score. Among those without erosions on the initial radiograph
(121), DXR–BMDa at baseline did not predict the new occurrence of erosions.
Conclusion. Increased disease activity and severity are associated with accelerated bone loss. However,
lower BMDa did not predict the new occurrence of erosive disease.
Key words: Inflammatory arthritis, Digital X-ray radiogrammetry, Norfolk Arthritis Register, Radiological
erosions.
Introduction
Individuals with inflammatory arthritis (IA) are at increased
risk of bone loss and fracture. The level of disease activity
is linked with greater bone loss, as measured at the spine,
hip or hand using dual energy X-ray absorptiometry (DXA)
[1–4].
Radiogrammetry, developed in the 1960s, was based on
morphometric measurements of cortical bone width
(metacarpal bones) on hand radiographs to provide an es-
timate of bone mass [5]. The method was widely used and
inexpensive; however, with manual use of callipers for the
measurement precision was limited [coefficient of variation
(CV)%=8–11%] [6]. Other X-ray-based absorptiometry
methods (DXA and QCT) for quantitative assessment of
the skeleton subsequently replaced radiogrammetry.
However, over the past decade computer vision tech-
niques [active shape/appearance models (ASM/AAM)]
have been applied to the measurements [digital X-ray
radiogrammetry (DXR) Pronosco A/S, HERLEV, Region
Hovedstaden, Denmark] resulting in improved precision
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E(CV=0.6–1.0%) [7–11]. Areal bone mineral density (BMDa)
assessed using DXR has been shown to correlate well with
central and peripheral DXA [12].
Hand radiographs are part of routine management of
RA and IA, and therefore DXR provides a method for
quantifying BMDa in these patients. Data from
cross-sectional studies of RA patients suggest that a re-
duction in DXR–BMDa is associated with markers of dis-
ease severity [13–20]. Less is known about the influence
of disease activity and functional variables with data from
both cross-sectional and prospective studies providing
inconsistent results [18, 20–23]. If hand bone loss using
DXR is to be considered as an outcome measure or prog-
nostic indicator of IA, it should be associated with meas-
ures of disease activity and severity.
We studied women recruited to the Norfolk Arthritis
Register (NOAR), a unique primary care-based cohort of
adults with recent onset of IA, in which information about
disease activity is recorded in a standardized fashion. The
aim of this analysis was to assess the validity of DXR as a
research tool in patients with IA by determining the influ-
ence of disease-related variables on hand cortical bone
loss in early IA. We also examined whether hand cortical
bone mass can predict the subsequent development of
erosive disease.
Methods
Patients
Patients were recruited from the NOAR, a primary
care-based inception cohort of adults aged 516 years
with early IA based in Norfolk, UK. Patients are included
in the register if they have two or more swollen joints for a
period of at least 4 weeks, with a symptom onset since 1
January 1990. Detailed methods for the study have been
published previously [24]. All aspects of the study were
approved by the Norwich Research Ethics Committee. All
patients gave written informed consent before entering
into the study.
Assessment
At baseline, patients were assessed by a research nurse
using a structured questionnaire and completed the
British version of the HAQ [25]. The nurse-administered
questionnaire covered smoking, previous hormone ther-
apy use and menopausal status. The nurse also examined
the joints for swelling, tenderness and deformity. A blood
sample was taken for the measurement of CRP and RF.
Patients were followed prospectively including assess-
ment at 5 years. Height and weight were measured in a
standardized manner at 5 years.
Radiographs
The 1987 ACR classification criteria for RA were applied at
the baseline and first-year visits [26]. Radiographs of the
hands and feet were performed 1 year after the baseline
assessment if patients satisfied the ACR criteria for RA or
if the presence of erosions would enable them to satisfy
these criteria [26]. Radiographs were performed at Year 5
on all subjects who consented, and then again at Year 10
if erosive change was present on the 5-year radiograph.
Radiographs were independently scored by two obser-
vers using Larsen’s method [27]. In 2005, hand radio-
graphs from participants who had at least two sets of
radiographs were analysed using DXR (Sectra Pronosco
X-Posure system; Sectra Imtec AB, Linko ¨ping, Sweden).
After digitization of the X-ray the narrowest parts of the
shafts of the second, third and fourth metacarpals were
identified and, for set lengths of these metacarpals (se-
cond=2cm; third=1.8cm and fourth=1.6cm), the cor-
tical width, bone width, metacarpal index (MCI) and
BMD (BMDa g/cm
2) were calculated automatically.
Further details have been described previously [11]. The
precision (hand analysis only) in this cohort (n=30) with
duplicate digitization and analysis was CV=0.19% and
standardized coefficient of variation (SCV)=0.35%.
Analysis
The analysis was restricted to women with an onset of
symptoms before 2000, an initial radiograph performed
within 2 years of the baseline assessment and at least
one follow-up radiograph. The relatively small number of
men fulfilling these criteria precluded meaningful analysis.
Using baseline joint counts, we calculated a
(CRP-derived) disease activity 28-joint assessment score
(DAS-28) [29]. Linear regression was used to determine
the association between DXR and BMDa assessed on
the initial radiograph and the various arthritis and
non-arthritis-related risk factors assessed at baseline,
with DXR–BMDa as the dependent variable and adjust-
ments made for age, height and weight. Results are ex-
pressed as b-coefficients (g/cm
2) and 95% CI. Linear
mixed models were used to determine the impact of base-
line arthritis and non-arthritis-related variables on the
within-subject change in DXR–BMDa (using serial radio-
graphs) with the results expressed as mean change
in DXR–BMDa with time (g/cm
2/year). Among patients,
who were free from erosions on their initial radiograph,
we used logistic regression to determine whether DXR–
BMDa predicted the occurrence of new erosions in the
subsequent radiographs.
We explored (also using linear regression) whether
DXR–BMDa based on assessment of the initial radiograph
predicted change in disease-related variables between
Years 1 and 5. The changes in disease-related variables
were logarithmically transformed if their distribution was
skewed. Finally, we used Spearman’s rank correlation
coefficient to examine the correlation between change in
DXR–BMDa and change in disease-related factors be-
tween Years 1 and 5. Statistical analysis was performed
using STATA v9.2 (Stata Corp, College Station, TX, USA,
2008).
Results
Subject characteristics
Two hundred and four women, mean (S.D.) age
55.1 (14.0) years, were included in the analysis. Mean
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smokers; 45% were post-menopausal and of these,
13.0% reported taking HRT (Table 1). The median
swollen joint count was 8 and tender joint count 8; 37%
of patients had a positive RF and 81% satisfied the ACR
criteria for RA at baseline (Table 2). With respect to the
radiographs at Year 1, the mean (S.D.) Larsen score at
Year 1 was 8.8 (11.8) and 39% of patients had radiological
erosions.
DXR–BMDa
One hundred and twenty-two had two films and 82 had
three or more. The median time between first and
follow-up radiographs was 4 years (interquartile range
3.8–4.4). Mean BMDa on the initial radiograph was 0.527
and 0.499g/cm
2 on the subsequent film. The mean
within-subject change in BMDa was 0.024g/cm
2,a n
1% decline per year.
Determinants of BMDa and change in BMDa
Age at baseline was associated with a lower BMDa at
baseline (b-coefficient per 10 years=0.035; 95% CI
0.041, 0.029), see Fig. 1. Ever use of the oral contra-
ceptive pill (OCP) was significantly associated with higher
BMDa (b-coefficient=0.024; 95% CI 0.004, 0.045) as was
HRT use (b-coefficient=0.020) although the CIs around
the parameter estimates embraced unity. Parity and
smoking were not linked with BMDa. A higher swollen
joint count was associated with lower BMDa (upper vs
lower tertile, b-coefficient=0.028) (Table 3). Individuals
satisfying the ACR criteria had a lower BMDa than
those who did not (b-coefficient=0.028; 95%
CI 0.050, 0.007). BMDa was lower in those with
higher CRP, Larsen score, HAQ score and DAS-28
although the CIs around the parameter estimates
embraced unity.
Those in the highest tertile of CRP had a greater rate of
subsequent bone loss than those in the lowest tertile
group (0.007 vs 0.003g/cm
2/year) (Table 4). This was
true also for DAS-28 (0.005 vs 0.001g/cm
2/year) and
Larsen score (0.007 vs 0.004g/cm
2/year). None of the
other arthritis-related variables predicted accelerated
bone loss.
We then examined whether change in disease-related
variables between Years 1 and 5 was associated with
baseline DXR–BMDa and also change in DXR–BMDa be-
tween Years 1 and 5. Change in disease-related variables
was not associated with either baseline DXR–BMDa or
change in DXR–BMDa between Years 1 and 5. Change
in DXR–BMDa was similar in those taking steroids at
Year 1 and/or Year 5 compared with those not taking
steroids at either time point.
DXR–BMDa and joint damage
Among those without erosions on the initial radiograph
(n=121), after adjusting for age at onset, height and
weight,DXR–BMDadidnotpredictthedevelopmentofero-
sions (odds ratio/per S.D. change in DXR–BMDa=0.72;
95% CI=0.4,1.2). Mean (S.D.) Larsen score was 8.8
(11.8) on the first radiograph and 19.2 (22.2) at follow-up.
DXR–BMDa at baseline (expressed as a Z-score, with
adjustments for age at onset, height, weight and baseline
Larsen score) did not predict a change in Larsen score
(after log transformation) during follow-up (b-coefficient=
0.18; 95% CI=0.46, 0.1).
FIG.1DXR–BMDa at Year 1 by age.
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TABLE 2 Disease-related characteristics measured at
baseline
Variable n=204
CRP, mean (S.D.), mg/l 19.7 (38.6)
DAS-28, mean (S.D.) 4.6 (1.3)
HAQ score (0–3), mean (S.D.) 1.1 (0.7)
Number of swollen joints (0–28), median (IQR) 8 (4–14)
Number of tender joints (0–28), median (IQR) 8 (3–15)
Number of both swollen
and tender joints (0–28), median (IQR)
5 (1–9)
RF positive (titre51/40), % 36.9
Satisfied ACR RA criteria (4/7 definition), % 80.9
Currently taking steroids, % 8.9
TABLE 1 Baseline demographic characteristics
Variable n=204
Age at interview, mean (s.D.), years 55.1 (14.0)
Height
a, mean (s.D.), m 1.6 (0.1)
Weight
a, mean (s.D.), kg 69.4 (13.2)
Age at natural menopause
b,
mean (s.D.), years
49.3 (4.5)
Post-menopausal, % 45.1
Current smoker, % 17.7
Ever taken OCP, % 43.6
Ever taken HRT
b, % 13.0
aHeight and weight were measured at the fifth anniversary
visit.
bOf the 45.1% women who were post-menopausal.
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Inflammatory arthritis and BMDDiscussion
In this population-based inception cohort of women with
IA, BMDa assessed by DXR declined by 1% per year.
Measures of disease activity including CRP and DAS-28,
and disease severity predicted subsequent cortical bone
loss in the hand. However, bone mass did not predict the
development of erosive disease.
Our study used standard methods of clinical assess-
ment. The patients were deliberately selected to include
all cases of IA and not just those with RA. Indeed, we have
shown that assigning criteria for RA is unstable in this
setting during the first 5 years of disease [24]. Clinical as-
sessment of disease activity is subject to measurement
error; in an attempt to minimize this, all of the assess-
ments were undertaken by trained research nurses, and
formal assessment of inter- and intra-observer variation in
assessment of joint counts was good. Any misclassifica-
tion related to measurement error would tend to reduce
the likelihood of finding significant associations. The hand
radiographs were assessed on the same radiogrammetry
device and precision was good (standardized CV 0.35%).
The procedure for taking hand radiographs was, however,
not standardized. It is possible that differences between
machines used may have contributed to some impreci-
sion; however, the effect of any such imprecision would
be to tend to reduce the chance of finding significant
associations. Subjects who had undergone hand radio-
graphs had more severe disease as determined by
higher joint counts and CRP. Such selection factors are,
however, unlikely to have influenced the strength of the
TABLE 4 Influence of disease-related factors on change in
DXR–BMDa in women
Mean changea (95% CI) in
DXR–BMDa, g/cm
2/year
Swollen joint count tertiles
Lower Ref: 0.005 (0.007, 0.003)
Mid 0.006 (0.008, 0.004)
Upper 0.004 (0.006, 0.002)
Tender joint count tertiles
Lower Ref: 0.006 (0.008, 0.004)
Mid 0.004 (0.006, 0.003)
Upper 0.005 (0.007, 0.003)
Both S+T joint count tertiles
Lower Ref: 0.005 (0.007, 0.003)
Mid 0.005 (0.007, 0.003)
Upper 0.005 (0.007, 0.003)
CRP tertiles
Lower Ref: 0.003 (0.005, 0.001)
Mid 0.004 (0.007, 0.002)
Upper 0.007 (0.010, 0.005)*
DAS-28
<3.2 Ref: 0.001 (0.004, 0.004)
3.2–5.1 0.005 (0.007, 0.003)*
>5.1 0.005 (0.008, 0.003)*
HAQ score tertiles
Lower Ref: 0.004 (0.006, 0.003)
Mid 0.004 (0.006, 0.002)
Upper 0.007 (0.008, 0.005)
Larsen score at
Year 1 tertiles
Lower Ref: 0.004 (0.006, 0.002)
Mid 0.003 (0.005, 0.001)
Upper 0.007 (0.009, 0.005)*
Erosions at Year 1
No Ref: 0.004 (0.006, 0.003)
Yes 0.006 (0.007, 0.004)
RF positive
No Ref: 0.004 (0.006, 0.003)
Yes 0.006 (0.008, 0.004)
Satisfy ACR criteria
No Ref: 0.004 (0.007, 0.001)
Yes 0.005 (0.006, 0.004)
Current steroid use
No Ref: 0.005 (0.006, 0.004)
Yes 0.006 (0.010, 0.002)
aAdjusted for age, height and weight. *P<0.05 compared
with referent category. S+T: swollen and tender.
TABLE 3 Influence of disease-related factors on DXR–
BMDa at Year 1 in women
DXR–BMDa, g/cm
2
b-coefficient
a (95% CI)
Swollen joint count tertiles
Lower Referent
Mid 0.022 (0.042, 0.001)*
Upper 0.028 (0.047, 0.008)*
Tender joint count tertiles
Lower Referent
Mid 0.003 (0.017, 0.023)
Upper 0.005 (0.016, 0.026)
Both S+T joint count tertiles
Lower Referent
Mid 0.006 (0.014, 0.026)
Upper 0.010 (0.031, 0.011)
CRP tertiles
Lower Referent
Mid 0.003 (0.028, 0.022)
Upper 0.008 (0.032, 0.017)
DAS-28
<3.2 Referent
3.2–5.1 0.007 (0.038, 0.024)
>5.1 0.004 (0.037, 0.028)
HAQ score tertiles
Lower Referent
Mid 0.018 (0.039, 0.002)
Upper 0.010 (0.030, 0.010)
Larsen score at Year 1 tertiles
Lower Referent
Mid 0.012 (0.033, 0.010)
Upper 0.018 (0.038, 0.002)
Erosions at Year 1 (yes vs no) 0.017 (0.034, 0.001)
RF positive (yes vs no) 0.004 (0.024, 0.015)
Satisfy ACR criteria (yes vs no) 0.028 (0.050, 0.007)*
Current steroid use (yes vs no) 0.006 (0.037, 0.026)
aAdjusted for age, height and weight. *P<0.05. S+T:
swollen and tender.
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internal comparison of those who contributed data. DXR
provides an estimate of cortical bone, which is less meta-
bolically active than trabecular bone, and therefore poten-
tially less responsive to change or metabolic effects. Bone
loss using radiogrammetry has, however, been shown to
be associated with clinically relevant outcomes, including
fracture, in patients with RA and elderly women [13, 30].
Finally, our data were related to a cohort of Caucasian
women living in the Norfolk (UK) area and so may not be
applicable beyond this group.
Quantitative measurements by DXR from hand radio-
graphs have been proposed as outcome measures and
prognostic indicators of disease course in RA [17, 18, 22].
However, there are few data from prospective studies that
examine the influence of disease-related factors, including
disease activity and function on subsequent bone loss
assessed using DXR. If bone loss is to be a valid outcome
measure in IA, it should reflect changes in both disease
severity and disease activity. Data from cross-sectional
studies suggest an association between DXR–BMDa and
markers of disease severity including Larsen score [13–
15, 17–19], Sharp scores [15, 20] and Steinbrocker scores
[14, 15, 17]. Jensen (2004) in a 2-year prospective study
reported accelerated bone loss in patients with erosive
disease [21], whereas Guler-Yuksel (2009) reported no
link with erosive disease at baseline, but change in erosive
status from baseline to 1 year did predict subsequent
bone loss [23]. Our data are broadly consistent with
these findings.
In relation to disease activity, data from prospective
studies provide discrepant results: with disease activity
as assessed using DAS-28 linked with bone loss in one,
but not another, study [22, 23]. Our data, which are based
on a cohort of patients with relatively early disease con-
firm that active disease assessed using the DAS-28 and
CRP is associated with accelerated bone loss. Change in
disease activity was not correlated with change in DXR–
BMDa suggesting that radiogrammetry is not a marker of
persistent disease activity. As with disease activity there
are few prospective data examining the impact of function
and the data are conflicting [22,23].
As expected, DXR–BMDa decreased with age. DXR–
BMDa was associated with increased past use of OCP
and HRT, though the latter failed to attain statistical sig-
nificance, probably due to small numbers.
In a small pilot study of 24 RA patients, change in DXR–
BMDa between baseline and Year 1 predicted erosive dis-
ease at 4 years [31]. In a larger study, based on the
European Research on Incapacitating Disease and
Social Support (EURIDISS) cohort, bone loss in the first
year was associated with progressive joint damage as-
sessed by the Sharp score at 5 and 10 years [32]. In con-
trast to these observations, our study suggests that bone
mass assessed at a single time point is unrelated to pro-
gressive joint damage. It may be that serial radiographs
are required to provide an estimation of change in bone
mass to predict worsening joint damage, and measure-
ment at a single time point is not predictive of joint
damage. Alternatively, differences in the study design/
populations sampled may partly explain these negative
findings. We also found no evidence that bone mass as
assessed by DXR–BMDa assessed at a single time point
was associated with the subsequent increase in disease
activity or impaired function suggesting that it is not a
marker of disease evolution.
In conclusion, DXR–BMDa is a simple, sensitive and
precise method of detecting change in hand cortical
bone mass in women with early IA. Increased disease ac-
tivity and severity are associated with accelerated bone
loss, supporting the role of DXR as a research tool, not
only in new studies but also retrospectively as hand radio-
graphs are an integral part of disease management in
patients with IA.
Rheumatology key messages
. DXR is a sensitive method of detecting change in
hand cortical BMDa.
. Increased disease activity and severity are asso-
ciated with bone loss.
. Reduced BMDa did not predict the new occurrence
of erosive disease.
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